International Research Consortium
HallucinoGenes
Investigating the genetic architecture of psychedelic use through the first multi-cohort genome-wide association meta-analysis of this phenotype.
Join the Consortium ↓
Investigating the genetic architecture of psychedelic use through the first multi-cohort genome-wide association meta-analysis of this phenotype.
Join the Consortium ↓HallucinoGenes is an international consortium that brings together research groups from around the world to conduct the first large-scale genome-wide association study (GWAS) meta-analysis of hallucinogen use. By pooling GWAS summary statistics across cohorts, we maximise statistical power to detect genetic variants associated with individual differences in hallucinogen use, without sharing any individual-level data.
Each cohort runs a standardised GWAS on their own data using a shared analysis plan. Your data never leaves your hands.
Only aggregate summary statistics are contributed. No individual-level data is transferred, ensuring full privacy protection.
We combine results across all cohorts in a meta-analysis, increasing statistical power for variant discovery.
We welcome all cohorts with genotype data and hallucinogen use phenotypes. Participation is straightforward, we provide a harmonized analysis plan.